Dr. Henry Greenberg is an Associate Professor of Clinical Medicine and a member of the faculty of the Institute of Human Nutrition at Columbia University College of Physicians and Surgeons. He is a long-standing member of the division of cardiology at St. Luke’s Roosevelt Hospital Center, and was the Associate Director of Cardiology until 2011 when stepped down to begin his faculty commitment at the Mailman School of Public Health where he is an Associate Professor of Clinical Medicine, in Epidemiology. He teaches a course on the global impact of cardiovascular diseases
Dr. Greenberg is a graduate of Tufts University School of Medicine. After a medical internship at St. Elizabeth’s Hospital in Boston, he spent 2 years in the United States Public Health Service as a Peace Corps Physician in Cameroon, West Africa. He returned to New York and complete and medical residency and cardiology fellowship at St. Luke’s and Roosevelt hospitals and has remained on the teaching faculty of the now combined institution since
His area of investigation has focused on clinical trials examining various aspects of coronary artery disease. He has participated in various roles in many national and international trials. Currently he is on the MADIT executive committee, the leading ICD (defibrillator) and CRT (resynchronization) trial group.
For the past 15 years he has revived his interest in global health, but with a focus on chronic illness, especially cardiovascular disease. He has consulted widely in Eastern Europe, Russia, and most recently, the Gulf States. He was a co-author of A Race against Time, a 2004 study of the impact of cardiovascular disease in 5 emerging economies prepared for the Earth Institute at Columbia, and many other recent publications.
Dr. Greenberg has had a long relationship with the New York Academy of Sciences. He organized conferences and edited the proceedings for the Academy’s Annals series on Sudden Death, U.S. Health Care Policy, and medical education. He served on the Board of Governors for many years and was its chairman in 1995-1996. He chaired the Academy’s Committee on the Human Rights of Scientists for 5 years, until 2011.
He is the editor-in chief of Progress in Cardiovascular Diseases. In the July 2010 issue he co-guest edited a symposium on the Global Impact of the Framingham Heart Study.